Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China

BACKGROUND: The new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has produced a global pandemic of coronavirus disease 2019 (COVID-19), resulting in modifications to public health policies on a universal scale. SARS-CoV-2 vaccine has evolved as the most effective and secu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Sheng-Wei, Chen, Jin-Yan, Wan, Rong, Pan, De-Jian, Yang, Wei-Lin, Zhou, Ren-Gui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649546/
https://www.ncbi.nlm.nih.gov/pubmed/36387801
http://dx.doi.org/10.12998/wjcc.v10.i31.11411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649546/
https://www.ncbi.nlm.nih.gov/pubmed/36387801
http://dx.doi.org/10.12998/wjcc.v10.i31.11411

Ejemplares similares